Some investors are just starting to have enough of Facebook (FB) , especially after the Cambridge Analytical uproar that sent the social media's stock tanking about 7% on Monday. 

"I think people are exhausted by Facebook, they are exhausted by having to deal with a company that doesn't seem to recognize that they don't have a lot of friends," TheStreet's founder Jim Cramer said on his 'Cramer Live' podcast (below). "I think they feel as though they are liked so to speak, and they're not."

For Cramer and his Action Alerts Plus research team, it saw the writing on the wall months ago for long-time holding Facebook.

"Taking a step back, we identified Facebook as a position that we needed to right-size early on in 2018, trimming shares at higher prices at the end of January, and also in late February," the Action Alerts Plus team told club members Monday. "We acted on the stock out of our disciplined portfolio management style as the position represented over 6% of the portfolio, thus carrying too much single stock risk -- simultaneously, we locked in terrific triple-digit gains and raised funds during a critical time of market volatility."

To be sure, the Facebook short-sellers are anything but tired out. In fact, they are hoping the selling continues.

Facebook short-sellers have netted $326 million in paper profits from Mar. 12 to Mar. 19, according to S3 Analytics. More broadly, those shorting FAANG (Facebook, Amazon (AMZN) , Apple (AAPL) , Netflix (NFLX) and Alphabet (GOOGL) ) have made in $1.59 billion in paper profits since Mar. 12.

More from Opinion

Micron Falls on Soft Guidance: 5 Key Takeaways

Micron Falls on Soft Guidance: 5 Key Takeaways

Tuesday Turnaround: Fed Up With the Fed Yet?

Tuesday Turnaround: Fed Up With the Fed Yet?

10 Tech Stocks That Have Gotten a Lot Cheaper Over the Last 3 Months

10 Tech Stocks That Have Gotten a Lot Cheaper Over the Last 3 Months

Oracle Gains on Better-Than-Feared Results and Guidance: 5 Key Takeaways

Oracle Gains on Better-Than-Feared Results and Guidance: 5 Key Takeaways

Monday Madness: Johnson & Johnson Is Still Making Headlines

Monday Madness: Johnson & Johnson Is Still Making Headlines